Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20091
20101
20111
20121
20162
20172
20182
20191
20204
20214
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated7
Recruiting5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Eli Lilly and Company2
Aduro Biotech, Inc.1
Astellas Pharma Inc1
BicycleTx Limited1
Bristol-Myers Squibb1
Centre de recherche du Centre hospitalier universitaire de Sherbrooke1
Esperas Pharma Inc.1
Kiadis Pharma1
LigaChem Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms24
Breast Neoplasms9
Endometrial Neoplasms9
Triple Negative Breast Neoplasms7
Fallopian Tube Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Neoplasm Metastasis5
Neoplasms5
Urinary Bladder Neoplasms5

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.